Skip to main content

Applied Genetic Technologies Corp

AGTCDelisted Dec 1, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001273636

Applied Genetic Technologies Corp was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Dec 1, 2022; 45 institutions reported holding it in 13F filings for Q3 2022, worth $3.34M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Applied Genetic Technologies Corp changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of AGTC: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders71164−6
Shares13.9M1.00K13.1M−845.6K (−6.1%)
Value$53.9M$3.00K$38.9M−$15.0M (−27.8%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Applied Genetic Technologies Corp at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to AGTC in Q3 2021
InstitutionSharesValue% of portfolio
Susquehanna Fundamental Investments, LLC82,850$249.0K0.00%
Marshall Wace, LLP20,411$61.0K0.00%
The PNC Financial Services Group, Inc.5,000$15.0K0.00%
Founders Capital Management3,000$9.00K0.01%
First Manhattan Co1,000$3.00K0.00%
Eaton Vance Management1,000$00.00%
Wagner Wealth Management, LLC75$00.00%

Sold out (13)

Institutions that held Applied Genetic Technologies Corp at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of AGTC in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Tibra Equities Europe Ltd78,100$305.0K
Jump Financial, LLC41,100$161.0K
LMR Partners LLP24,664$96.0K
Pinz Capital Management, LP19,900$78.0K
Personal Cfo Solutions, LLC17,776$70.0K
Royal Bank of Canada16,172$63.0K
Y-Intercept (Hong Kong) Ltd10,004$39.0K
UBS Group AG1,671$7.00K
Stonepine Capital Management, LLC1,000$4.00K
Citigroup Inc400$2.00K
New York State Common Retirement Fund356$1.00K
Aspire Private Capital, LLC200$1.00K
FMR LLC2$0

Not filed for Q3 2021 yet (1)

Institutions that held Applied Genetic Technologies Corp at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AGTC in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
First Horizon Corp1,000$3.00K